/Companies

Molecule AI

23 known investors

Find your way into Molecule AI

Sign up to find every way you can get introduced to Molecule AI

  • Your email: who you already know at Molecule AI, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Molecule AI team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs. It also features labs such as an autonomous AI agent for peptide drug discovery.

Founders & leadership

PKPaul Kohlhaas
Paul KohlhaasFounderFounder at Molecule

Investors · 23

Shine Capitallisted by Shine CapitalNew York · $1M – $10M

How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Also in the syndicate · 3

Atmos VenturesleadInVenturesSunfish Partners

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

Molecule ONEMolecule.one applies machine learning to chemical synthesis, predicting synthetic routes and supporting chemistry research with an in-house synthetic and analytical laboratory. It serves pharmaceutical and life-science research through its computational and experimental chemistry platform.
MoleculeMolecule is a trade and risk management (ETRM/CTRM) platform for energy and commodity trading operations, automating deal capture, market-data pricing, and calculation of positions, P&L, and risk. It supports 50+ commodities including power, renewables, gas, and crude, and offers reporting, FCM reconciliation across clearing firms, and flexible APIs.
EmoleculeseMolecules operates a digital chemical search platform and procurement service connecting researchers to over 83 million available chemical compounds from a global supplier network. The company serves drug discovery researchers and biopharmaceutical organizations seeking to reduce timelines and improve efficiencies in early-stage compound acquisition and management.
Molecular DevicesMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
CoinGeckoCoinGecko is the world's largest independent cryptocurrency data aggregator, providing comprehensive market data including price, volume, and market capitalization across thousands of cryptoassets. It serves millions of users globally with tools, research, and APIs for cryptocurrency market analysis and insights.

Companies working in the same space as Molecule AI.

Frequently asked questions

What does Molecule AI do?
Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs. It also features labs such as an autonomous AI agent for peptide drug discovery.
Who founded Molecule AI?
Molecule AI was founded by Paul Kohlhaas.
Who are Molecule AI's investors?
Molecule AI's investors include Atria Ventures, Backed, BoxGroup, Compound, Fifty Years, Incrypt Blockchain, Inflection.xyz, Lunar Ventures and 12 more.